PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

Round-up of the latest research on lung cancer

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma

Developments in clinical trials and health information technology that will improve targeted therapies for patients

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction

Genomic marker predicts anti-PD-1 response in several cancers

Nivolumab extends survival for NSCLC

Nivolumab extends survival for patients with the most common lung cancer

Genomic marker predicts anti-PD-1 response in several cancers

'Liquid biopsy' may help earlier detection of lung cancer treatment resistance

Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer